A Study of Single and Multiple Doses HRS9531 Tablets in Healthy Subjects
Status:
COMPLETED
Trial end date:
2024-10-08
Target enrollment:
Participant gender:
Summary
The study is being conducted to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple doses of HRS9531tablets in healthy subjects.